← Back to all trials
Not Yet Recruiting
NCT07800390
proState Cancer Health Education to pRomote Early sreENing Uptake (SCREEN): A Pilot Randomised Control Trial
Conditions: Anxiety, Prostate Cancer, Health Education, Screening and Brief Interventions, Screening, Wellbeing
Sex: Male
Ages: 18 Years – 70 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 74
Sponsor: Teesside University
Summary
Prostate cancer is an issue of significant public health concern. Yet in low- and middle-income countries like Nigeria, men are adversely affected due to factors including poor early prostate cancer screening uptake. Yet a gap remains in addressing this urgent problem. The proposed study seeks to pilot the feasibility and acceptability of a novel co-produced workshop intervention called "proState Cancer awareness education to pRomote Early screENing uptake (SCREEN) with men who are not or partially up to date with their screening. The SCREEN intervention is designed to raise awareness of prostate cancer, its symptoms, implications for late screening, the benefits of early screening, avenues for screening uptake, and also addressing anxiety related to screening uptake. The SCREEN intervention is low-intensity and lasts approximately two hours. The proposed study also aims to pilot and test the instrument to determine its effectiveness and cost-effectiveness, including the mechanism by which the intervention might work.
Eligibility Criteria
Inclusion Criteria:
* Men aged between age 18 years and 79 who are not or partially up to date with prostate cancer
* Able to provide full consent for their participation.
* Able to speak the English Language. Able to take part in the intervention and are available for the intervention assessment at baseline and end of intervention.
Exclusion Criteria:
* Less than 18 years
* Unable to consent.
* Currently undergoing severe mental health treatment.
* Unable to speak the English language
* not meeting the inclusion criteria.
Source: ClinicalTrials.gov (NCT07800390). StuddyBuddy aggregates publicly available trial information.